Aviragen Stockholder Sues For Meeting Before $60M Merger
An Aviragen Therapeutics Inc. stockholder sued the company in Delaware's Chancery Court late Tuesday, seeking to force a stockholder meeting in the wake of Aviragen's agreement to a stock exchange merger...To view the full article, register now.
Already a subscriber? Click here to view full article